NDC 59368-003-01 - up and up dye free infants concentrated ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-003
- Requested NDC
- 59368-003-01
- Package NDCs from labels
- 59368-003-01, 59368-003-02
- Manufacturer
- Sixarp, LLC
- Effective date
- 2024-03-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| up and up dye free infants concentrated ibuprofen - Sixarp, LLC | Sixarp, LLC | 2024-03-15 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | Aurohealth LLC | 0ade8ee2-7c74-4b05-925e-d92742fc2b90 | 2022-03-03 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | cf6fbf3b-a0f3-4e08-a981-d183fa285758 | 2022-03-03 | Warnings | WK2XYI10QM |
| Diphenhydramine HCl and Ibuprofen | DIPHENHYDRAMINE HCL AND IBUPROFEN | Aurohealth LLC | a656f8b0-8cb4-4802-b8d3-7b95c0265d56 | 2022-02-21 | Warnings | WK2XYI10QM |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | XF417D3PSL | |
| Sterile Water | WATER | American Regent, Inc. | 78b35864-4bbc-4759-a5c1-7e4f25e22932 | 2022-01-31 | Boxed warning | 059QF0KO0R |
| Ibuprofen | IBUPROFEN | Aphena Pharma Solutions - Tennessee, LLC | 91723661-d0bb-4498-ac59-59bbdc334230 | 2022-01-27 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen and Pseudoephedrine HCl | IBUPROFEN AND PSEUDOEPHEDRINE HCL | Aurohealth LLC | 6adf9292-b4af-4cb4-99f3-dda03734570a | 2022-01-21 | Warnings | WK2XYI10QM |
| Pain Relief - Ibuprofen 200 mg | IBUPROFEN | Health Pharma USA LLC | d60a6a11-8c06-cede-e053-2a95a90af7f9 | 2022-01-20 | Warnings | WK2XYI10QM |
| Concentrated ibuprofen infants | IBUPROFEN | Wal-Mart Stores, Inc. | 00b7fc71-8cf0-4c12-a479-146408f7f91b | 2022-01-11 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | RITE AID CORPORATION | a7aa790a-6d6c-7929-e053-2995a90a1cf8 | 2022-01-04 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | RITE AID | a7abf95e-d444-42da-e053-2995a90a88d3 | 2022-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | RITE AID | a7ac8b55-2758-400e-e053-2995a90a0eed | 2022-01-03 | Warnings | WK2XYI10QM |
| TH-101 | CALC CARB, CARBO VEG, CHELIDONIUM MAJ, COQ10, FUCUS, GRAPHITES, HOMEOPATHIC GLYCOPROTEIN COMPLEX, HYPOTHALAMUS, KALI PHOS, LYCOPODIUM, MAG PHOS, NAT MUR, NAT PHOS, NUX VOM, ORNITHOGALUM, PHYTOLACCA, PITUITARUM, PLACENTA, SINAPIS ARV FLOS, QUERCUS GLAND SP, QUERCUS ROB | Temple Health Nutrition, LLC | d54bb860-560c-4f8f-9aea-a0b7774cc92b | 2021-12-29 | Warnings | C151H8M554 |
| Sterile Diluent for Treprostinil | WATER | Dr.Reddy's Laboratories Inc., | 33050ee2-519b-1f0b-d4df-9e14dd329c57 | 2021-12-23 | Warnings, Adverse reactions | 059QF0KO0R |
| Ibuprofen | IBUPROFEN | MARKSANS PHARMA LIMITED | 3c8df1e5-61bc-4e70-b6b9-8973986ad589 | 2021-12-21 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | MARKSANS PHARMA LIMITED | 859d7190-586f-4766-a7e7-9e800a72d58b | 2021-12-21 | Warnings | WK2XYI10QM |
| basic care childrens ibuprofen | IBUPROFEN | Amazon.com Services LLC | 0dec2df9-ba8b-4bc7-b617-773aa08f9273 | 2021-12-20 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | Allegiant Health | 8ba06ba0-bfe9-4626-af65-dae4d6a3a2ad | 2021-12-06 | Warnings | WK2XYI10QM |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | d763511e-f1a7-4014-94b9-f7ad8f023ff4 | 2021-12-02 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | cf9f43a0-c750-4cf0-ac49-176ab2105aab | 2021-12-02 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.